· Metabolism and transport of chemotherapeutic agents
· Drug resistance
In addition to pre-packaged kits for point -of -service use, we provide diagnostic testing services in support of cancer research and treatment for biopharmaceutical companies, academic institutions and governmental agencies.
AmoyDx aims to improve the quality of diagnostics and efficacy of treatment for cancer patients, and to move discoveries from the bench to the bedside. The company possesses key patents and technology affiliations with a variety of hospitals, biopharmaceutical companies and academic institutions. It is led by an executive group with a proven record of success and has recruited over 40 scientists with indepth experience in product development, commercialization, marketing, sales, laboratory service and technical alliances.
AmoyDx was founded in 2007 and is located at Xiamen Hi- Tech Park with over 3000 sq.m. office, laboratory and GMP manufacture. AmoyDx has been awarded the Medical Device Manufacturing License by theState Food and Drug Administration of China(SFDA) and has been issued certifications of Quality Management System and ISO13485 by China and the European Union respectively.